Isoform-specific expression of VEGF-B in normal tissues and tumors

Growth Factors

Volumn 19, Issue 1, 2001, Pages 49-59

  Li, X ^a   Aase, K ^a   Li, H ^a   Von Euler, G ^a   Eriksson, U ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

Cell line; Isoform; Regulation; Tumor; VEGF B

Indexed keywords

ISOPROTEIN; PLATELET DERIVED GROWTH FACTOR; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL SPECIFICITY; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TECHNIQUE; TISSUE SPECIFICITY; TUMOR CELL LINE;

EID: 0034795750     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.3109/08977190109001075     Document Type: Article

References (27)

1. Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature
2. VEGF-B deficient mice display an atrial conduction defect
3. A retention signal necessary and sufficient for Golgi localization maps to the cytoplasmic tail of a Bunyaviridae (Uukuniemi virus) membrane glycoprotein
4. Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa
5. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature and impaired recovery from cardiac ischemia
6. Placenta growth factor: Identification and characterization of a novel isoform generated by RNA alternative splicing
7. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development
8. Transgenic mouse models in angiogenesis and cardiovascular disease
9. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188)
10. Tissue-specific expression pattern of vascular endothelial growth factor isoforms in the malignant transformation of lung and colon
11. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction
12. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas
13. Comparison of Vegf, Vegf-B, Vegf-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
14. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors
15. Cloning and characterization of a novel human gene related to vascular endothelial growth factor
16. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
17. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (P1GF), are transcribed from a single gene of chromosome 14
18. Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1
19. Vascular endothelial growth factor (VEGF) and its receptors
20. Expression of vascular endothelial growth factors A, B, C and D and their relationships to lymph node status in lung adenocarcinoma
21. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
22. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform
23. Structure, expression and receptor-binding properties of placenta growth factor (P1GF)
24. 145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
25. Vascular endothelial growth factors Vegf-B and Vegf-C are expressed in human tumors
26. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors
27. Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes - Implication in autocrine and paracrine regulation of angiogenesis